Al-Dawaa Medical Services Company (TADAWUL:4163)

Market Cap	3.68B -46.7%
Revenue (ttm)	6.63B +0.6%
Net Income	238.84M -37.1%
EPS	2.80 -37.3%
Shares Out	85.00M
PE Ratio	15.43
Forward PE	12.01
Dividend	2.52 (5.83%)
Ex-Dividend Date	Jul 5, 2026

Volume	256,118
Open	43.28
Previous Close	43.28
Day's Range	43.00 - 43.32
52-Week Range	43.00 - 80.05
Beta	-0.04
Analysts	Hold
Price Target	60.53 (+39.92%)
Earnings Date	Aug 2, 2026

About TADAWUL:4163

Al-Dawaa Medical Services Company, together with its subsidiaries, primarily operates as a pharmaceutical retail company in the Kingdom of Saudi Arabia and Kingdom of Bahrain. The company offers medicines, perfumes, cosmetics, beauty tools, and other pharmaceutical products; and transportation and logistics services. It is also involved in online wholesale of pharmaceutical products, pharmaceutical agents, wholesale of pharmaceutical goods, related pharmacy activities, pharmaceutical warehousing activities, retail of medical equipment and other...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1993
• Country: Saudi Arabia
• Stock Exchange: Saudi Stock Exchange
• Ticker Symbol: 4163

Financial Performance

In 2025, TADAWUL:4163's revenue was 6.74 billion, an increase of 4.37% compared to the previous year's 6.45 billion. Earnings were 321.76 million, a decrease of -8.44%.

Analyst Summary

According to 8 analysts, the average rating for 4163 stock is "Hold." The 12-month stock price target is SAR 60.53, which is an increase of 39.92% from the latest price.

Price Target

SAR 60.53

(39.92% upside)

Analyst Consensus: Hold